HealthEquity (HQY)
(Delayed Data from NSDQ)
$79.04 USD
-0.16 (-0.20%)
Updated Apr 25, 2024 04:00 PM ET
3-Hold of 5 3
C Value B Growth A Momentum B VGM
Cash flow Statements
Fiscal Year End for HealthEquity, Inc falls in the month of January.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
1/31/2024 | 1/31/2023 | 1/31/2022 | 1/31/2021 | 1/31/2020 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 55.71 | -26.14 | -44.29 | 8.83 | 39.66 |
Depreciation/Amortization & Depletion | 155.93 | 164.46 | 141.64 | 121.01 | 55.35 |
Net Change from Assets/Liabilities | -33.13 | -33.37 | 1.63 | 12.30 | -10.36 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 64.31 | 45.70 | 42.02 | 39.48 | 20.36 |
Net Cash From Operating Activities | 242.83 | 150.65 | 141.00 | 181.62 | 105.01 |
Property & Equipment | -42.82 | -48.54 | -71.62 | -64.59 | -32.94 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | -504.53 | 0.00 | -1,644.58 |
Investments | 0.00 | 0.00 | 2.37 | 0.00 | -53.85 |
Other Investing Activities | -3.26 | -70.58 | -65.47 | -32.37 | -9.13 |
Net Cash from Investing Activities | -46.07 | -119.13 | -639.25 | -96.96 | -1,740.49 |
Uses of Funds
1/31/2024 | 1/31/2023 | 1/31/2022 | 1/31/2021 | 1/31/2020 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 6.47 | 6.68 | 466.39 | 295.35 | 469.84 |
Issuance (Repayment) of Debt | -54.38 | -8.75 | -53.13 | -239.06 | 1,242.19 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.87 | -0.60 | -18.41 | -3.86 | -246.29 |
Net Cash from Financing Activities | -47.04 | -2.67 | 394.86 | 52.42 | 1,465.74 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 149.71 | 28.85 | -103.39 | 137.08 | -169.75 |
Cash at Beginning of Period | 254.27 | 225.41 | 328.80 | 191.73 | 361.48 |
Cash at End of Period | 403.98 | 254.27 | 225.41 | 328.80 | 191.73 |
Diluted Net EPS | 0.64 | -0.31 | -0.53 | 0.12 | 0.58 |
Fiscal Year End for HealthEquity, Inc falls in the month of January.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
1/31/2024 | 10/31/2023 | 7/31/2023 | 4/30/2023 | 1/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 55.71 | 29.35 | 14.68 | 4.09 | -26.14 |
Depreciation/Amortization & Depletion | 155.93 | 117.32 | 78.85 | 39.82 | 164.46 |
Net Change from Assets/Liabilities | -33.13 | -26.08 | -16.17 | -31.00 | -33.37 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 64.31 | 45.17 | 31.30 | 18.62 | 45.70 |
Net Cash From Operating Activities | 242.83 | 165.75 | 108.65 | 31.54 | 150.65 |
Property & Equipment | -42.82 | -31.55 | -19.38 | -9.14 | -48.54 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | -3.26 | -3.26 | 0.00 | 0.00 | -70.58 |
Net Cash from Investing Activities | -46.07 | -34.80 | -19.38 | -9.14 | -119.13 |
Uses of Funds
1/31/2024 | 10/31/2023 | 7/31/2023 | 4/30/2023 | 1/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 6.47 | 3.40 | 1.35 | 0.92 | 6.68 |
Issuance (Repayment) of Debt | -54.38 | -54.38 | -54.38 | -54.38 | -8.75 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.87 | -0.18 | -0.16 | 2.43 | -0.60 |
Net Cash from Financing Activities | -47.04 | -51.15 | -53.18 | -51.03 | -2.67 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 149.71 | 79.80 | 36.08 | -28.62 | 28.85 |
Cash at Beginning of Period | 254.27 | 254.27 | 254.27 | 254.27 | 225.41 |
Cash at End of Period | 403.98 | 334.06 | 290.35 | 225.64 | 254.27 |
Diluted Net EPS | 0.30 | 0.17 | 0.12 | 0.05 | 0.00 |